Drugs by condition
Drugs approved for atrial fibrillation
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
26
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
10
New molecular entities and new biologics
In development
9
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for atrial fibrillation.
- Eliquis (Apixaban) · Bristol Priority reviewApr 17, 2025
- Diltiazem Hydrochloride In 0.72% Sodium Chloride (Diltiazem Hydrochloride) · Hq Spclt Pharma Feb 21, 2025
- Rapiblyk (Landiolol Hydrochloride) · Aop Hlth US NovelNov 22, 2024
- Esmolol Hydrochloride Double Strength In Plastic Container (Esmolol Hydrochloride) · Hq Spclt Pharma Apr 7, 2016
- Savaysa (Edoxaban Tosylate) · Daiichi Sankyo INC NovelJan 8, 2015
All approved drugs for atrial fibrillation, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 136 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Factor Xa Inhibitor (3)
Antiarrhythmic (2)
Cardiac Glycoside (2)
Class not listed in FDA's data (19)
- Rapiblyk Landiolol Hydrochloride · Aop Hlth US · 2024
- Savaysa Edoxaban Tosylate · Daiichi Sankyo INC · 2015
- Pradaxa Dabigatran Etexilate Mesylate · Boehringer Ingelheim · 2010
- Corvert Ibutilide Fumarate · Pfizer · 1995
- Betapace Sotalol Hydrochloride · Legacy · 1992
- Brevibloc Esmolol Hydrochloride · Baxter Hlthcare · 1986
- Diltiazem Hydrochloride In 0.72% Sodium Chloride Diltiazem Hydrochloride · Hq Spclt Pharma · 2025
- Esmolol Hydrochloride Double Strength In Plastic Container Esmolol Hydrochloride · Hq Spclt Pharma · 2016
- Sotylize Sotalol Hydrochloride · Azurity · 2014
- Heparin Sodium Heparin Sodium · Pfizer · 2011
- Sotalol Hydrochloride Sotalol Hydrochloride · Altathera Pharms LLC · 2009
- Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container Heparin Sodium · B Braun · 1992
- Heparin Sodium 25,000 Units In Sodium Chloride 0.45% In Plastic Container Heparin Sodium · B Braun · 1992
- Heparin Sodium 10,000 Units In Dextrose 5% In Plastic Container Heparin Sodium · Hospira · 1985
- Verapamil Hydrochloride Verapamil Hydrochloride · Exela Pharma · 1984
- Heparin Sodium 25,000 Units In Sodium Chloride 0.9% In Plastic Container Heparin Sodium · Hospira · 1984
- Heparin Sodium Heparin Sodium · Fresenius Kabi USA · 1978
- Heparin Sodium Heparin Sodium · Hikma · 1972
- Heparin Sodium 25,000 Units In Sodium Chloride 0.45% Heparin Sodium · Fresenius Kabi USA · 1972
Drugs in development for atrial fibrillation
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- REGN7508CenvacibartPhase 312 trials
Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism
- REGN9933amrecibartPhase 35 trials
Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)
- AbelacimabMAA868Phase 33 trials
Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke
- MilvexianJNJ-70033093, BMS-986177Phase 33 trials
Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- AP31969Phase 21 trial
Acesion Pharma · Atrial Fibrillation (AF)
- BAY 3670549Phase 21 trial
Bayer · Atrial Fibrillation
- HBI-3000sulcardine sulfatePhase 21 trial
HUYABIO International, LLC. · Atrial Fibrillation
- PKN605Phase 21 trial
Novartis · Atrial Fibrillation
2 discontinued brand-name drugs whose label still names it
- Lanoxin Pediatric Digoxin
- Xarelto Rivaroxaban
More on atrial fibrillation: recruiting trials · published research
Related in cardiovascular and metabolic: Type 2 diabetes · Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.